Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2022-01-07 Director's Dealing
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
110年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related parties' holdings. It is focused on insider shareholdings and their changes or status. There is no indication of financial statements, earnings data, or management discussion. The document is not a report or announcement of a meeting or voting results. It is a disclosure of insider shareholdings, which aligns with the category of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and contains detailed insider shareholding data, not just an announcement or link to a report, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the best classification is DIRS with high confidence.
2022-01-07 Chinese
110年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory announcements, and no mention of any report publication. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing. The document length is very short (602 characters), and it is not an announcement of a report publication but a direct disclosure. Therefore, it fits best under Regulatory Filings (RNS).
2021-12-10 Chinese
110年11月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month and year (民國110年11月, which corresponds to November 2021). The content is concise but includes substantive financial data and analysis, not merely an announcement or a link to a report. It is not a full annual or interim report but a periodic financial summary with actual figures. This fits the definition of an Interim / Quarterly Report (IR), which covers financial data for a period shorter than a full fiscal year and includes substantive financial data and analysis. The document is 776 characters long, which is short but contains actual financial data, so it is not a report publication announcement or regulatory filing. Therefore, the best classification is IR (Interim / Quarterly Report).
2021-12-10 Chinese
110年11月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, senior management, and related parties. It includes data on shares held at appointment, changes during the month, and current holdings, with specific mention of insiders such as the chairman, directors, general manager, and others. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of voting results or a proxy statement, but a detailed insider shareholding disclosure. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just a brief announcement or certification.
2021-12-08 Chinese
110年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related party holdings. The content focuses on insider shareholdings and their changes, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is under 5,000 characters and is a direct disclosure of insider shareholdings rather than an announcement of a report or a certification. Therefore, the document fits best into the category of Director's Dealing (DIRS).
2021-12-08 Chinese
110年11月內部人持股轉讓(事前)
Director's Dealing Classification · 100% confidence The document contains a table listing share transfer details by insiders, including dates, company codes, names, transfer methods, and share quantities. It specifically mentions '法人董事代表人配偶' (spouse of a corporate director) and '法人董事代表人本人' (the director themselves), indicating insider share transactions. The content is about personal share transactions by company directors and executives, which matches the definition of Director's Dealing filings. The document length is short and focused solely on insider share dealings, not a broader financial report or announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-11-23 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.